ANZ News
It is a home-based programme with 10 self-paced modules.
One of the projects will develop a digital navigator to support people with chronic conditions.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
The company also has pending approvals for the device in Australia and Thailand.
The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.
It also plans to double its headcount over the next 12 months.
It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.
It has also entered into a collaboration with The Pharmacy Guild of Australia for health service initiatives.
The VR app has been shown to reduce 75% of phobia symptoms after six weeks of treatment.
Also, annalise.ai has made key executive appointments to support its global expansion.